This inventor holds 1 USPTO granted patent. Top assignee: Fujirebio Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Kaoru Nakatsubo: Innovator in Immunoassay Technology
Introduction
Kaoru Nakatsubo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunoassay technology, particularly in the measurement of human C-peptide. His innovative work has led to the development of a patented method that enhances the accuracy and efficiency of immunoassays.
Latest Patents
Kaoru Nakatsubo holds a patent for an "Immunoassay for measuring human C-peptide and kit therefor." This patent describes a method for selectively measuring human C-peptide in a sample. The process involves reacting human C-peptide with a first anti-human C-peptide antibody and a second anti-human C-peptide antibody, which is immobilized on a solid support. The resulting immune complex is then separated from non-reacted antibodies and quantified. The first and second antibodies are designed to recognize different epitopes within the same region of the human C-peptide, allowing for simultaneous binding.
Career Highlights
Kaoru Nakatsubo is associated with Fujirebio Inc., a company known for its advancements in diagnostic technologies. His work at Fujirebio has been instrumental in developing innovative solutions for medical diagnostics. With a focus on immunoassays, Nakatsubo has contributed to enhancing the reliability of tests used in clinical settings.
Collaborations
Throughout his career, Nakatsubo has collaborated with notable colleagues, including Isao Nishizono and Sachiko Kitajima. These collaborations have fostered a productive environment for research and development, leading to advancements in immunoassay technologies.
Conclusion
Kaoru Nakatsubo's contributions to immunoassay technology exemplify the impact of innovation in the medical field. His patented methods for measuring human C-peptide represent a significant advancement in diagnostic capabilities. Through his work at Fujirebio Inc. and collaborations with esteemed colleagues, Nakatsubo continues to influence the landscape of medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile